Medical News Summary: New breast cancer drug faces imminent approval
About: New breast cancer drug faces imminent approval
Date: 7 January 2005
Source: Bloomberg
Medical News Summary (summary of medical news story as reported by Bloomberg): A new drug by Schering is set to receive FDA approval upon the provision of additional information. The drug is called Bonefos and it claims to stop breast cancer metastasizing to the bones. It reduces pain and makes bones stronger by restoring the balance between destruction of old bone cells and replacement of new ones. Once breast cancer metastasizes to the bones, the life expectancy is about two years. The drug’s approval process was sped up when studies showed that the drug cut breast-cancer deaths by 23% compared to a placebo in a study involving 1,069 subjects. The drug is already approved by 79 countries for use in treatment bone loss following chemotherapy in premenopausal women and increases bone density in postmenopausal breast cancer patients. It also treats excess calcium in the blood. The drug’s advantage over competitors is that it is administered orally or intravenously compared to its rivals which can only be administered intravenously. Thus it is a more viable long-term treatment option.
URL: http://www.bloomberg.com/apps/news?pid=10000100&sid=auq53G0GtJF0&refer=germany
Related Disease Topics: Breast cancer, Menopause, Bone loss (see Weak bones)
Related Symptom Topics: Pain
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Chemotherapy
- medication and cancer
- medication and bone cancer
- medication and breast cancer
- medication and menopause
- medication and bone loss
- medication and pain
- research and cancer
- research and bone cancer
- research and breast cancer
- research and menopause
- Research and bone loss
- research and pain
Medical Tools & Articles:
Next articles:
Medical Articles: